Céline Cano
Cancer Research UK(GB)Newcastle University(GB)
Publications by Year
Research Areas
Cancer-related Molecular Pathways, Cancer therapeutics and mechanisms, Biochemical and Molecular Research, Bioactive Compounds and Antitumor Agents, DNA Repair Mechanisms
Most-Cited Works
- → Chemosensitization of Cancer Cells by KU-0060648, a Dual Inhibitor of DNA-PK and PI-3K(2012)129 cited
- → Identification and Characterization of an Irreversible Inhibitor of CDK2(2015)118 cited
- → Cyclin-Dependent Kinase (CDK) Inhibitors: Structure–Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines(2016)113 cited
- → Synthetic cannabinoid receptor agonists: classification and nomenclature(2019)109 cited
- → FragLites—Minimal, Halogenated Fragments Displaying Pharmacophore Doublets. An Efficient Approach to Druggability Assessment and Hit Generation(2019)102 cited
- → DNA-Dependent Protein Kinase Is a Therapeutic Target and an Indicator of Poor Prognosis in B-Cell Chronic Lymphocytic Leukemia(2008)91 cited
- → Pyranone, Thiopyranone, and Pyridone Inhibitors of Phosphatidylinositol 3-Kinase Related Kinases. Structure−Activity Relationships for DNA-Dependent Protein Kinase Inhibition, and Identification of the First Potent and Selective Inhibitor of the Ataxia Telangiectasia Mutated Kinase(2007)82 cited
- → Targeting DNA‐Dependent Protein Kinase for Cancer Therapy(2017)77 cited
- → Selective DNA-PKcs inhibition extends the therapeutic index of localized radiotherapy and chemotherapy(2019)65 cited
- → Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination(2011)63 cited